1.655
China Pharma Holdings Inc. Borsa (CPHI) Ultime notizie
China pharma projects disrupted by Sino-US tensions - Reuters
CPHI Price Target: Can CPHI Reach $4? Trading Analysis and Key Levels - Blockchain News
CPHI Stock Squeeze Alert: Potential Short Squeeze Trading Opportunity Analyzed - Blockchain News
CPHI’s Stock Market Adventure: -20.60% YTD Growth Amidst Volatility - investchronicle.com
CPHI Stock Surges with Above-Average Volume: Key Trading Insights and Crypto Market Impact - Blockchain News
CPHI High Conviction Stock Analysis: Potential for Overnight Surge Similar to JZ and SRMTrading Strategies and Crypto Market Impact - Blockchain News
US pharma bets big on China to snap up potential blockbuster drugs - Yahoo Finance
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL - Yahoo Finance
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Kalkine : China Pharma Shares Moved on NYSE Composite This Week - Kalkine Media
China Pharma (NYSE:CPHI) Shares Down 0.2% – Here’s What Happened - Defense World
CPHI Stock Surge: Key Price Levels and Crypto Market Implications for 2025 - Blockchain News
Trump tariffs live updates: US, China agree on plan to ease trade tensions as US appeals court allows tariffs to remain in effect - Yahoo Finance
Trump tariffs live updates: US-China trade framework set, now awaits Trump and Xi nod - Yahoo Finance
PBM and CPHI Stock Analysis: Trading Signals and Crypto Market Impact for 2024 - Blockchain News
Trump tariffs live updates: Trump hikes steel and aluminum tariffs to 50%, spares UK - Yahoo Finance
Trump’s tariff threat exposes China’s tight grip on the global pharmaceuticals industry - CNN
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report - Yahoo Finance
CPHI Stock Analysis: Current Position and Dry Eye Device Catalyst Update - Blockchain News
Jane Street Group LLC Has $508,000 Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Deutsche Bank AG Increases Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World
$CPHI Stock Surges on Unusual Volume: Real-Time Trading Analysis and Crypto Market Impact - Blockchain News
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Chinese firm Livzon spends over $219 mln to acquire 64.8% stake in Vietnam's Imexpharm - Theinvestor
Drug Discovery Services Market 2025–2032: Value Chain Analysis and Key Growth Contributors - newstrail.com
$CPHI Stock Surges with Unusual Volume: Crypto Market Implications and Real-Time Analysis - Blockchain News
China Pharma (NYSE:CPHI) Stock Rating Upgraded by StockNews.com - Defense World
HSI Up 348 pts; HSTI Up 60 pts; CSPC PHARMA Up over 6%; BYD COMPANY, CHINA MOBILE, HSBC HOLDINGS, BOC HONG KONG, 3SBIO Hit New Highs; Market Turnover Rises - AASTOCKS.com
Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - Defense World
Tariffs live updates: Bessent says tariffs may return to 'reciprocal' levels if deals aren't made - Yahoo Finance
Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake - Yahoo Finance
Inozyme Pharma, Emerson Electric, Stanley Black & Decker - TradingView
Nuance Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-CHINA Trial for COPD - Yahoo Finance
FTSE 100 LIVE: Stocks rise on US-China hopes, miners rally whilst AstraZeneca tumbles - Proactive Investors
Trump tariffs live updates: Trump hails 'very good progress' as US-China talks continue - Yahoo Finance
Trump tariffs live updates: Trump floats slashing China tariffs to 80% with 'many' deals 'in the hopper' - Yahoo Finance
Trump tariffs live updates: Trump announces UK trade deal with US-China trade talk date set - Yahoo Finance
Trump tariffs live updates: Trump meets with Canada's Carney, hints at coming pharma tariffs - Yahoo Finance
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Trump tariffs live updates: China says 'door is open' to trade talks with the US - Yahoo Finance
US business lobby in China: Some pharma firms reporting tariff exemptions - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines - Yahoo Finance
Is China Pharma Holdings Inc (AMEX: CPHI) A Good Investment For New Investors Now? - Stocksregister
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
27.81%! LONGi Refreshes the World Record for the Efficiency of Monocrystalline Silicon Cells Again - digitalmore.co
WuXi group wrestles with uncertainty over pharma tariffs - Bamboo Works
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask - marketscreener.com
CPHI stock touches 52-week high of $1.4 amid market fluctuations By Investing.com - Investing.com South Africa
Trump tariffs live updates: Trump reluctant to escalate China tariffs, says 'going to make a deal' - Yahoo Finance
CPHI stock touches 52-week high of $1.4 amid market fluctuations - Investing.com India
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested - The Globe and Mail
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):